Monday, December 6

Moderna shares plummet after slashing 2021 sales forecast

The actions of Modern fall 17% after announcing its forecast cut in COVID-19 vaccine sales for the year and failing to meet its earnings and revenue expectations for the third quarter. Yesterday, the Nasdaq-listed company had closed almost 3% down in the pre-announcement.